Search
Castle Biosciences Inc
CSTLAdd to Watchlist
24.110USD
-0.600-2.43%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
731.26MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Castle Biosciences Inc is 9.11, ranking 3 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 37.50, with a high of 45.00 and a low of 30.00.
Analyst Rating
Based on
9
analysts
Strong Buy
Current Rating
43.556
Target Price
+79.09%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Castle Biosciences Inc
CSTL
9
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
32
Stryker Corp
SYK
31
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Castle Biosciences Inc's expected revenue for the next quarter?
Castle Biosciences Inc's expected revenue is 86.37M.
What is Castle Biosciences Inc's price target?
Analysts forecast that Castle Biosciences Inc's price target is USD 37.50, with the highest forecast at USD 45.00 and the lowest forecast at USD 30.00.
How have Castle Biosciences IncCSTL's recent earnings per share performed?
The market expectation was USD -0.49, while Castle Biosciences IncCSTL's earnings per share (EPS) for the previous quarter was USD -0.08. EPS for the next quarter is expected at USD -0.40.
What is the analyst rating for Castle Biosciences Inc?
Based on the ratings of Castle Biosciences Inc's stock from 9 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.